Search results
Sep 29, 2023 · Joe Arron and Mark Eisner worked together for about a decade at Genentech, with broad remits but a shared passion for interstitial lung disease. They’d go their separate ways a few years ago — Arron to 23andMe as chief scientific officer of its therapeutics push and Eisner to FibroGen, where he led the medical operations.
Sep 27, 2021 · Sep. 27, 2021, 09:56 PM. LOS ANGELES, Sept. 27, 2021 /PRNewswire/ -- Byron Allen'sAllen Media Group proudly announces the elevation of Mark Eisner to Senior Vice President of Content...
He completed residency training in internal medicine, served as Chief Medical Resident, and pursued advanced fellowship training in pulmonary and critical care medicine at the University of California, San Francisco. He also received a M.P.H. degree from the University of California, Berkeley School of Public Health.
- Chief Medical Officer
- Fibrogen Inc, Fibrogen Inc
View Mark Eisner’s profile on LinkedIn, a professional community of 1 billion members. Experience: Sonoma Biotherapeutics · Education: Stanford University · Location: San Francisco Bay Area ...
- 500+
- Sonoma Biotherapeutics
- 4K
- San Francisco Bay Area
First, Eisner made it clear that he thought the jury was still out on whether Iger’s biggest move since taking the job -- the acquisition of Pixar Animation Studios for $7.4 billion -- would...
Summary. Experience. Personal Network. Company connections. Profile. Dr. Mark Eisner, MD, is a Chief Medical Officer at FibroGen, Inc. Dr. Eisner was previously employed as a Senior Vice President by Genentech, Inc. and a Professor by The University of California, San Francisco.
Eisner did have some great success at Disney but became involved in a lawsuit regarding Jeffrey Katzenberg (the former Disney movie studio head) and a severance package worth millions that was given to Michael Ovitz (he served as Disney president under Eisner for a brief period of time).
